Meeder Asset Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-728
| Closed | -$18K | – | 2664 |
|
|
2021
Q1 | $18K | Buy |
+728
| New | +$18K | ﹤0.01% | 1445 |
|
|
2020
Q4 | – | Sell |
-1,438
| Closed | -$26K | – | 2228 |
|
|
2020
Q3 | $26K | Buy |
+1,438
| New | +$26K | ﹤0.01% | 1097 |
|
|
2020
Q1 | – | Sell |
-1,645
| Closed | -$23K | – | 2537 |
|
|
2019
Q4 | $23K | Sell |
1,645
-2,366
| -59% | -$33.1K | ﹤0.01% | 1308 |
|
|
2019
Q3 | $47K | Buy |
4,011
+3,470
| +641% | +$40.7K | ﹤0.01% | 1039 |
|
|
2019
Q2 | $11K | Buy |
+541
| New | +$11K | ﹤0.01% | 1434 |
|
|
2018
Q4 | – | Sell |
-4,663
| Closed | -$135K | – | 1809 |
|
|
2018
Q3 | $135K | Buy |
4,663
+3,541
| +316% | +$103K | 0.01% | 581 |
|
|
2018
Q2 | $30.6K | Buy |
1,122
+268
| +31% | +$7.31K | ﹤0.01% | 874 |
|
|
2018
Q1 | $19K | Buy |
854
+433
| +103% | +$9.63K | ﹤0.01% | 905 |
|
|
2017
Q4 | $9K | Buy |
421
+296
| +237% | +$6.33K | ﹤0.01% | 1164 |
|
|
2017
Q3 | $3K | Buy |
+125
| New | +$3K | ﹤0.01% | 1387 |
|
|
2017
Q2 | – | Sell |
-766
| Closed | -$14K | – | 1879 |
|
|
2017
Q1 | $14K | Buy |
+766
| New | +$14K | ﹤0.01% | 789 |
|